XAIR - צמיחת הכנסות ב-12 חודשים נגררים Beyond Air, Inc.

The rolling 12-month year-over-year sales growth rate demonstrates stability driven by the optimization of supply chains and inventory reserves. This trend is supported by the expansion of LungFit systems into US clinics, although it is constrained by slow technology adoption and insurance barriers. The current mark of 42.00 indicates the level of operational business expansion for Beyond Air, Inc. (XAIR) within the therapeutic equipment segment.
Beyond Air Inc (XAIR) - פילוחי מדדים ודוחות פיננסיים

This indicator measures the annual revenue growth rate over a rolling twelve-month period, separating the fundamental trend from short-term noise. The metric enables a business stress test by identifying organic growth versus artificial expansion through acquisitions. By analyzing year-over-year sales dynamics over the last 12 months (TTM), an investor assesses scaling efficiency. For Beyond Air, Inc. (XAIR), this is critical, as the costs of bringing nitric oxide systems to market exceed current revenues. A high growth rate here must justify the cash deficit and the procurement of borrowed funds.